This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Mobile version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us   Jan. 10, 2013

 



The association of center performance evaluations and kidney transplant volume in the US
American Journal of Transplantation    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Report cards evaluating transplant center performance have received significant attention in recent years corresponding with the Centers for Medicare and Medicaid Services issue of the 2007 Conditions of Participation. Our primary aim was to evaluate the association of report card evaluations with transplant center volume. More

Iso-Tex Diagnostics, Inc.

• We are an FDA licensed manufacturer.
• We label peptides, monoclonal antibodies, reagents, chemical   and proteins for cancer treatments.
• Our above products can be labeled with radioisotopes such as   I-125, I-131, P32, Tc99m, Y90 and AC-225.
• We have a multicurie isotope license and an animal facility.
 SOCIETY NEWS


Did you know?
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Pediatric Community of Practice has developed a list of resources available in the U.S. and Canada for educating students about organ transplantation. To access this information, simply click on the link PCOP Resource Center.

CEOT: Early registration ends Jan. 24
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Don't miss the opportunity to attend the first annual Cutting Edge of Transplantation (CEOT) meeting this Feb. 14-16 in Scottsdale, Ariz. Register now to take advantage of the buy one registration, get one half off deal and a discounted hotel rate. CEOT promises to be an exciting and informative event, with more than 30 talks from experts in the field of transplantation on issues surrounding B cells and antibodies.

C1qScreen™: A New Research Tool for AMR Risk
Identify Antibodies That May Compromise Graft Survival
  • Detect Presence of Complement Fixing Antibodies
  • Investigate risk of developing Antibody Mediated Rejection (AMR)
Request a Complimentary Sample Kit!
FREE SAMPLE

For Research Use Only. Not for use in diagnostic procedures.


Live and on-demand webinars free for AST members
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
AST offers two distinct webinar series for convenient online education catering to a wide audience; both are free to members and available for a fee to non-members. Visit a-s-t.org/T3 for the Timely Topics in Transplantation on-demand webinar series, and a-s-t.org/business for the live monthly Business of Transplantation webinar series (presented by the AST Transplant Administrators COP).

 TRANSPLANT NEWS


Influenza vaccination in solid-organ transplant recipients
Current Opinion in Organ Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In solid-organ transplant (SOT) recipients, influenza is associated with significant graft dysfunction and even mortality. A recent study reviewed the most recent literature on SOT recipients regarding the clinical significance of influenza and the immunogenicity and safety of influenza vaccine in this population. More

Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death
Liver Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Worsening donor liver quality resulting in decreased organ utilization may be contributing to the recent decline in liver transplants nationally. Researchers conducted a study to examine trends in donor liver utilization and the relationship between donor characteristics and nonuse. The United Network for Organ Sharing database was used to to review all deceased adult organ donors in the United States from whom at least one solid organ was transplanted into a recipient. More


Athena Diagnostics

Genetic testing can be a cost-effective way to increase the number of living related donor transplants. Mutational analysis may help direct long-term treatment plans, including pre-operative screening of potential kidney transplant recipients and living related donors.
WAVES by Waters Medical Systems
✓ Hypothermic preservation of a single kidney using physiologic pulsatile preservation and membrane oxygenation: a proven technology from Waters Medical Systems (more than 40 years clinical experience) ✓ Simplifies the perfusion process (provides more options to view, chart, and trend data, offers web-based remote monitoring, and a transportable design)
✓ Meets or exceeds current FDA standards and AOPO and UNOS Preservation Guidelines.
MNX: Organ Transportation
When it comes to saving lives, MNX understands organ transplant logistics. Every shipment is urgent, and every step critical. That’s why MNX offers specialty services that are tailored for organ transportation. From expedited ground service to charter flights, MNX has the proven experience and operational resources you can count on.


Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients
Nephrology (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cyclosporine (CsA), dosed to achieve C2 targets, has been shown to provide safe and efficacious immunosuppression when used with a mycophenolate and steroids for de novo kidney transplant recipients. A recent study examined whether use of enteric-coated mycophenolate sodium (EC-MPS) together with basiliximab and steroids would enable use of CsA dosed to reduced C2 targets in order to achieve improved graft function. More

Balancing accountable care with risk aversion: Transplantation as a model
American Journal of Transplantation    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Transplantation is widely regarded as a model of accountability and transparency in healthcare; however, failure to accurately measure and report appropriate performance metrics is likely to result in risk aversion and decreased access to transplant for higher risk populations. More



Survival of human islets in microbeads containing high guluronic acid alginate crosslinked with Ca2+ and Ba2+
Xenotransplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The main hurdles to the widespread use of islet transplantation for the treatment of type 1 diabetes continue to be the insufficient number of appropriate donors and the need for immunosuppression. Microencapsulation has been proposed as a means to protect transplanted islets from the host's immune system. More

Endoscopic retrograde cholangiopancreatography safe and effective for treatment of pancreaticobiliary disease following organ transplant in children
Pediatric Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
ERCP is a diagnostic and therapeutic imaging modality widely used in adult pancreaticobiliary disease, including the treatment of anastomotic strictures following liver and small bowel transplant. A recent study evaluated the safety of and indications for ERCP following abdominal organ transplant among pediatric patients by performing a subgroup analysis of a large cohort. More


Put Science on Your Side

Drug Monitoring Platforms since 1981.

Learn More
Advertise here!

To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact James DeBois at 469-420-2618.
MORE


Adverse drug interactions as a high-risk factor for lethal post-transplant complications in Chinese population
Clinical Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Metabolism of triazole antifungal agents is highly competitive to conventional post-transplant immunosuppressants like cyclosporine A (CsA) via the cytochrome P450-dependent pathway. This recently published report is the first on lethal complications that may arise due to this type of drug interaction. More

Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: Preliminary results of consecutive seven cases
Clinical Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
ABO-incompatibility is a major obstacle to expanding exiguous donor pools in adult liver transplantation, especially in countries where grafts from deceased donors are uncommon. A recent report documents preliminary results of ABO-incompatible (ABO-I) adult living donor liver transplantation (LDLT) using a new, simple protocol. More
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Jan. 3, 2012
Dec. 27, 2012
Dec. 20, 2012
Dec. 13, 2012






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063